Another Woodford darling collapses into administration
Investors still trapped in LF Equity Income are not affected, however, as the stake was sold in 2020
Acacia Research
-
-
Acacia pockets £16m from partial sale of former Woodford Oxford Nanopore stake
Share sale combined with value of US investor’s remaining stake represents a 78% uplift on biotech firm’s last valuation
-
Acacia looks to install its own directors in board shake-up of former Woodford biotech holding
US investor has slammed Arix Biosciences for its ‘history of governance instability’
-
Neil Woodford touts for institutional investors with details of eight-stock biotech portfolio
Document fishing for interest also lists a WCM Partners Healthcare (GP) Ltd at an address in the Cayman Islands
-
Link offloads remaining Woodford healthcare assets to Acacia
But £192m remains in the former Woodford Equity Income fund
-
Former Woodford healthcare stock grateful to finally land new owner
Link Fund Solutions had held a 12% stake in Sensyne Health
-
Woodford investors endure ‘another kick in the teeth’ as Synairgen quintuples
Biotech holding soars 550% one month after Link sold it on the cheap to Acacia Research
-
Acacia sells off more UK science stocks from Neil Woodford’s old fund
4D Pharma is currently trading at a fraction of the price it commanded during Woodford Equity Income’s heyday
-
Acacia Research shrugs off ‘silly’ criticism after swiftly flipping Woodford assets
US buyer describes the low purchase price of Midatech as ‘a function of the tax and accounting treatment’
-
Link accused of letting further middleman chip into Woodford investor savings
ACD transferred eight stakes valued at £150m to Acacia Research last week
